NCT02382588 arm group b0cc76cdc3a5ebe7d164d2a6d4beea96 [clinicaltrials_resource:NCT02382588/arm-group/b0cc76cdc3a5ebe7d164d2a6d4beea96]
arm group [clinicaltrials_vocabulary:arm-group]
NCT02382588 arm group b0cc76cdc3a5ebe7d164d2a6d4beea96 [clinicaltrials_resource:NCT02382588/arm-group/b0cc76cdc3a5ebe7d164d2a6d4beea96]
Bio2RDF identifier
NCT02382588/arm-group/b0cc76cdc3a5ebe7d164d2a6d4beea96
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... cc76cdc3a5ebe7d164d2a6d4beea96
description [clinicaltrials_vocabulary:description]
0.3% hypromellose gel to be ap ...... day for an additional 7 days.
identifier
clinicaltrials_resource:NCT02382588/arm-group/b0cc76cdc3a5ebe7d164d2a6d4beea96
title
NCT02382588 arm group b0cc76cdc3a5ebe7d164d2a6d4beea96
@en
type
label
NCT02382588 arm group b0cc76cd ...... c76cdc3a5ebe7d164d2a6d4beea96]
@en